Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Buy
1,216
+13
+1% +$5.24K 0.01% 239
2026
Q1
$430K Sell
1,203
-215
-15% -$76.5K 0.01% 239
2025
Q4
$452K Buy
1,418
+284
+25% +$101K 0.01% 227
2025
Q3
$424K Buy
1,134
+455
+67% +$165K 0.01% 214
2025
Q2
$242K Sell
679
-121
-15% -$37.3K 0.01% 284
2025
Q1
$217K Sell
800
-195
-20% -$60.7K 0.01% 280
2024
Q4
$330K Sell
995
-27
-3% -$9.48K 0.01% 227
2024
Q3
$339K Buy
1,022
+210
+26% +$64.2K 0.01% 220
2024
Q2
$255K Sell
812
-482
-37% -$156K 0.01% 251
2024
Q1
$405K Buy
1,294
+213
+20% +$58.2K 0.02% 217
2023
Q4
$260K Buy
1,081
+30
+3% +$6.62K 0.01% 261
2023
Q3
$224K Buy
+1,051
New +$227K 0.01% 258

Other funds holding ETN

Aspiriant LLC's ETN Position: Q2 2026 in Review

Aspiriant LLC increased its Eaton (ETN) stake by 1.1% in Q2 2026, buying an estimated $5.24K and bringing the position to 1,216 shares worth $518K. The position accounts for 0.01% of the portfolio, ranked #239.

Aspiriant LLC first reported a position in ETN in Q3 2023 and has held it in 12 quarters since. 2,670 funds tracked by Wall St. Rank hold ETN as of Q2 2026.

  • Aspiriant LLC held 1,216 shares of Eaton worth $518K as of Q2 2026.
  • Aspiriant LLC bought 13 Eaton shares in Q2 2026, an estimated $5.24K.
  • Eaton made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #239 holding.
  • Aspiriant LLC first reported a position in Eaton in Q3 2023 and has held it in 12 quarters since.
  • 2,670 funds tracked by Wall St. Rank held Eaton as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.